U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    MIR1296 microRNA 1296 [ Homo sapiens (human) ]

    Gene ID: 100302150, updated on 10-Oct-2023

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    CircSOD2 polarizes macrophages towards the M1 phenotype to alleviate cisplatin resistance in gastric cancer cells by targeting the miR-1296/STAT1 axis.

    CircSOD2 polarizes macrophages towards the M1 phenotype to alleviate cisplatin resistance in gastric cancer cells by targeting the miR-1296/STAT1 axis.
    Qu B, Liu J, Peng Z, Xiao Z, Li S, Wu J, Li S, Luo J.

    09/28/2023
    Circular RNA hsa_circ_0000519 contributes to angiogenesis and tumor progression in hepatocellular carcinoma through the miR-1296/E2F7 axis.

    Circular RNA hsa_circ_0000519 contributes to angiogenesis and tumor progression in hepatocellular carcinoma through the miR-1296/E2F7 axis.
    Liu Y, Tang H, Zhang Y, Wang Q, Li S, Wang Z, Shi X.

    03/16/2023
    Decreased AGGF1 facilitates the progression of placenta accreta spectrum via mediating the P53 signaling pathway under the regulation of miR-1296-5p.

    Decreased AGGF1 facilitates the progression of placenta accreta spectrum via mediating the P53 signaling pathway under the regulation of miR-1296-5p.
    Wang R, Zhao J, Liu C, Li S, Liu W, Cao Q.

    02/28/2023
    Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis.

    Circular RNA circ_0048764 promotes the development of breast cancer by regulating microRNA-1296-5p/tripartite motif containing 14 axis.
    Xie F, Xiong Y, Yan J, Wang L, Yan W., Free PMC Article

    02/26/2022
    microRNA-1296 Inhibits Glioma Cell Growth by Targeting ABL2.

    microRNA-1296 Inhibits Glioma Cell Growth by Targeting ABL2.
    Zhang G, Xia M, Guo J, Huang Y, Huang J, Wei K, Zhang X, Zeng J, Liang W., Free PMC Article

    11/27/2021
    MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2.

    MicroRNA-1296-5p suppresses the proliferation, migration, and invasion of human osteosarcoma cells by targeting NOTCH2.
    Wang L, Hu K, Chao Y, Wang X.

    05/15/2021
    Data show that serum microRNA-1296 is a more sensitive marker of nonalcoholic fatty liver disease (NAFLD) than blood lipids, which provides a new method for noninvasive early screening of NAFLD.

    Decreased Serum miR-1296 may Serve as an Early Biomarker for the Diagnosis of Non-Alcoholic Fatty Liver Disease.
    Yu F, Wang X, Zhao H, Hao Y, Wang W.

    03/14/2020
    A tumor-suppressive role of miR-1296-5p through the translational repression of oncogenic CDK6 and EGFR in gastric cancer.

    The tumor-suppressive function of miR-1296-5p by targeting EGFR and CDK6 in gastric cancer.
    Jia Y, Zhao LM, Bai HY, Zhang C, Dai SL, Lv HL, Shan BE., Free PMC Article

    07/27/2019
    Reduced miR-1296 expression confers metastasis and recurrence of hepatocellular carcinoma.SRPK1 is a direct target of miR-1296 in the hepatocellular carcinoma.PI3K/AKT signaling is essential for the biological function of miR-1296 in the epatocellular carcinoma.

    MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q, Liu X, Liu Z, Zhou Z, Wang Y, Tu J, Li L, Bao H, Yang L, Tu K., Free PMC Article

    08/18/2018
    Findings indicate cyclin D1 (CCND1) as a target of microRNA miR-1296.

    Tumor suppressor role of microRNA-1296 in triple-negative breast cancer.
    Phan B, Majid S, Ursu S, de Semir D, Nosrati M, Bezrookove V, Kashani-Sabet M, Dar AA., Free PMC Article

    12/2/2017
    miR-1296-5p might be involved in the regulation on the migration and invasion of human gastric cancer cells at least in part via targeting ERBB2/Rac1 signaling pathway.

    miR 1296-5p Inhibits the Migration and Invasion of Gastric Cancer Cells by Repressing ERBB2 Expression.
    Shan X, Wen W, Zhu D, Yan T, Cheng W, Huang Z, Zhang L, Zhang H, Wang T, Zhu W, Zhu Y, Zhu J., Free PMC Article

    08/19/2017
    firstprevious page of 1 nextlast